Circio Holding ASA (OSL:CRNA)

Norway flag Norway · Delayed Price · Currency is NOK
0.6270
-0.0330 (-5.00%)
At close: Oct 2, 2025
-5.00%
Market Cap68.24M
Revenue (ttm)n/a
Net Income (ttm)-6.60M
Shares Out108.84M
EPS (ttm)-0.11
PE Ration/a
Forward PE0.98
Dividendn/a
Ex-Dividend Daten/a
Volume2,554,044
Average Volume953,280
Open0.6800
Previous Close0.6600
Day's Range0.6050 - 0.6800
52-Week Range0.4800 - 3.3100
Beta1.52
RSI50.26
Earnings DateNov 6, 2025

About Circio Holding ASA

Circio Holding ASA, a biotechnology company, develops novel circular RNA and immunotherapy medicines. The company is developing TG01, a cancer vaccine targeting driver mutations, which is in three clinical trials for multiple myeloma, and pancreatic and lung cancer; and circVec circRNA vector platform, a modular genetic cassette for biogenesis of multifunctional circRNAs in human cells. It has a collaboration with Certest Biotec, S.L. for formulation of circVec. The company was formerly known as Targovax ASA and changed its name to Circio Holdi... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2010
Employees 10
Stock Exchange Oslo Børs
Ticker Symbol CRNA
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.